Authors

• Lúcio Lara Santos (ORCID: https://orcid.org/0000-0002-0521-5655)
• Luca Morelli (ORCID: https://orcid.org/0000-0002-7742-9556)
• M. Helena Vasconcelos (ORCID: https://orcid.org/0000-0002-7801-4643)
• Elisa Giovannetti (ORCID: https://orcid.org/0000-0002-7565-7504)
• Cristina P. R. Xavier (ORCID: https://orcid.org/0000-0002-4613-1917)
• Helena Branco (ORCID: https://orcid.org/0000-0003-1115-6839)
• Amir Avan (ORCID: https://orcid.org/0000-0002-4968-0962)
• Andreia Palmeira (ORCID: https://orcid.org/0000-0002-1391-2143)
• Sofia Martins Sousa (ORCID: https://orcid.org/0000-0002-3886-3923)

Institutions

• University of Pisa (IT)
• Mashhad University of Medical Sciences (IR)
• Universidade do Porto (PT)
• Fondazione Pisa (IT)
• Institut des Sciences Moléculaires (FR)
• Cooperativa de Ensino Superior Politécnico e Universitário (PT)
• Instituto Português de Oncologia Francisco Gentil (PT)
• IPO Porto (PT)
• Amsterdam University Medical Centers (NL)
• i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT)
• Cancer Center Amsterdam (NL)
• Vrije Universiteit Amsterdam (NL)

Publication Details

Journal

Cancer Chemotherapy and Pharmacology

Published

2024-09-03

DOI

https://doi.org/10.1007/s00280-024-04712-1

Citations

2

Primary Topic

Studies on Chitinases and Chitosanases

Type

article

Field-Weighted Citation Impact

0.47

Funders

• Universidade do Porto